The present disclosure provides macrocyclic compounds inspired by the immunophilin ligand family of natural products FK506 and rapamycin. The generation of a Rapafucin library of macrocyles that contain FK506 and rapamycin binding domains should have great potential as new leads for developing drugs to be used for treating diseases.
本公开提供了受免疫蛋白
配体家族FK506和
雷帕霉素天然产物启发的大环化合物。生成包含FK506和
雷帕霉素结合结构域的Rapafucin大环化合物库,应具有作为治疗疾病新药的潜力。